214 related articles for article (PubMed ID: 36982595)
1. Current and Future Therapeutical Options in Alport Syndrome.
Reiterová J; Tesař V
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982595
[TBL] [Abstract][Full Text] [Related]
2. Digenic Alport Syndrome.
Savige J; Renieri A; Ars E; Daga S; Pinto AM; Rothe H; Gale DP; Aksenova M; Cerkauskaite A; Bielska O; Lipska-Zietkiewicz B; Gibson JT
Clin J Am Soc Nephrol; 2022 Nov; 17(11):1697-1706. PubMed ID: 35675912
[TBL] [Abstract][Full Text] [Related]
3. COL4A3 mutation is an independent risk factor for poor prognosis in children with Alport syndrome.
Ozdemir G; Gulhan B; Atayar E; Saygılı S; Soylemezoglu O; Ozcakar ZB; Eroglu FK; Candan C; Demir BK; Soylu A; Yüksel S; Alpay H; Agbas A; Duzova A; Hayran M; Ozaltin F; Topaloglu R
Pediatr Nephrol; 2020 Oct; 35(10):1941-1952. PubMed ID: 32394188
[TBL] [Abstract][Full Text] [Related]
4. Possible Digenic Disease in a Caucasian Family with COL4A3 and COL4A5 Mutations.
Choi M; Anistan YM; Eckardt KU; Gollasch M; Nickel P
Nephron; 2019; 141(3):213-218. PubMed ID: 30661074
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic Variants in the Genes Affected in Alport Syndrome (COL4A3-COL4A5) and Their Association With Other Kidney Conditions: A Review.
Savige J; Harraka P
Am J Kidney Dis; 2021 Dec; 78(6):857-864. PubMed ID: 34245817
[TBL] [Abstract][Full Text] [Related]
6. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
[TBL] [Abstract][Full Text] [Related]
7. Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.
Papazachariou L; Papagregoriou G; Hadjipanagi D; Demosthenous P; Voskarides K; Koutsofti C; Stylianou K; Ioannou P; Xydakis D; Tzanakis I; Papadaki A; Kallivretakis N; Nikolakakis N; Perysinaki G; Gale DP; Diamantopoulos A; Goudas P; Goumenos D; Soloukides A; Boletis I; Melexopoulou C; Georgaki E; Frysira E; Komianou F; Grekas D; Paliouras C; Alivanis P; Vergoulas G; Pierides A; Daphnis E; Deltas C
Clin Genet; 2017 Nov; 92(5):517-527. PubMed ID: 28632965
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study.
Furlano M; Martínez V; Pybus M; Arce Y; Crespí J; Venegas MDP; Bullich G; Domingo A; Ayasreh N; Benito S; Lorente L; Ruíz P; Gonzalez VL; Arlandis R; Cabello E; Torres F; Guirado L; Ars E; Torra R
Am J Kidney Dis; 2021 Oct; 78(4):560-570.e1. PubMed ID: 33838161
[TBL] [Abstract][Full Text] [Related]
9. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
[TBL] [Abstract][Full Text] [Related]
10. Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis.
Pierides A; Voskarides K; Athanasiou Y; Ioannou K; Damianou L; Arsali M; Zavros M; Pierides M; Vargemezis V; Patsias C; Zouvani I; Elia A; Kyriacou K; Deltas C
Nephrol Dial Transplant; 2009 Sep; 24(9):2721-9. PubMed ID: 19357112
[TBL] [Abstract][Full Text] [Related]
11. COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.
Longo I; Porcedda P; Mari F; Giachino D; Meloni I; Deplano C; Brusco A; Bosio M; Massella L; Lavoratti G; Roccatello D; Frascá G; Mazzucco G; Muda AO; Conti M; Fasciolo F; Arrondel C; Heidet L; Renieri A; De Marchi M
Kidney Int; 2002 Jun; 61(6):1947-56. PubMed ID: 12028435
[TBL] [Abstract][Full Text] [Related]
12. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
[TBL] [Abstract][Full Text] [Related]
13. Genotype-phenotype correlations for COL4A3-COL4A5 variants resulting in Gly substitutions in Alport syndrome.
Gibson JT; Huang M; Shenelli Croos Dabrera M; Shukla K; Rothe H; Hilbert P; Deltas C; Storey H; Lipska-Ziętkiewicz BS; Chan MMY; Sadeghi-Alavijeh O; Gale DP; ; Cerkauskaite A; Savige J
Sci Rep; 2022 Feb; 12(1):2722. PubMed ID: 35177655
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for Genetic Testing and Management of Alport Syndrome.
Savige J; Lipska-Zietkiewicz BS; Watson E; Hertz JM; Deltas C; Mari F; Hilbert P; Plevova P; Byers P; Cerkauskaite A; Gregory M; Cerkauskiene R; Ljubanovic DG; Becherucci F; Errichiello C; Massella L; Aiello V; Lennon R; Hopkinson L; Koziell A; Lungu A; Rothe HM; Hoefele J; Zacchia M; Martic TN; Gupta A; van Eerde A; Gear S; Landini S; Palazzo V; Al-Rabadi L; Claes K; Corveleyn A; Van Hoof E; van Geel M; Williams M; Ashton E; Belge H; Ars E; Bierzynska A; Gangemi C; Renieri A; Storey H; Flinter F
Clin J Am Soc Nephrol; 2022 Jan; 17(1):143-154. PubMed ID: 34930753
[TBL] [Abstract][Full Text] [Related]
15. The COL4A3 and COL4A4 Digenic Mutations in cis Result in Benign Familial Hematuria in a Large Chinese Family.
Li A; Cui YX; Lv X; Liu JH; Gao EZ; Wei XX; Xia XY; Gao CL; Liu FX; Xia ZK; Asan ; Liu ZH; Li XJ
Cytogenet Genome Res; 2018; 154(3):132-136. PubMed ID: 29742505
[TBL] [Abstract][Full Text] [Related]
16. COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome.
Storey H; Savige J; Sivakumar V; Abbs S; Flinter FA
J Am Soc Nephrol; 2013 Dec; 24(12):1945-54. PubMed ID: 24052634
[TBL] [Abstract][Full Text] [Related]
17. COL4A5 and LAMA5 variants co-inherited in familial hematuria: digenic inheritance or genetic modifier effect?
Voskarides K; Papagregoriou G; Hadjipanagi D; Petrou I; Savva I; Elia A; Athanasiou Y; Pastelli A; Kkolou M; Hadjigavriel M; Stavrou C; Pierides A; Deltas C
BMC Nephrol; 2018 May; 19(1):114. PubMed ID: 29764427
[TBL] [Abstract][Full Text] [Related]
18. Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy.
Weber S; Strasser K; Rath S; Kittke A; Beicht S; Alberer M; Lange-Sperandio B; Hoyer PF; Benz MR; Ponsel S; Weber LT; Klein HG; Hoefele J
Pediatr Nephrol; 2016 Jun; 31(6):941-55. PubMed ID: 26809805
[TBL] [Abstract][Full Text] [Related]
19. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
20. Evidence of digenic inheritance in Alport syndrome.
Mencarelli MA; Heidet L; Storey H; van Geel M; Knebelmann B; Fallerini C; Miglietti N; Antonucci MF; Cetta F; Sayer JA; van den Wijngaard A; Yau S; Mari F; Bruttini M; Ariani F; Dahan K; Smeets B; Antignac C; Flinter F; Renieri A
J Med Genet; 2015 Mar; 52(3):163-74. PubMed ID: 25575550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
